A modern clinic for at-home treatments
(857) 240-1080
Holiday Sale! Get started today for only
$49 $4.99
Written and prepared by:
Corey Neff, Mackenzie Price, Gino Cioffi, Zhen Liu, Rabina Walsh, Jill S. Barnholtz-Sloan, Kyle M. Walsh, April K. S. Salama, Carey K. Anders, Peter E. Fecci, Quinn T. Ostrom
Discover the significant findings on the impact of atopy on cutaneous melanoma outcomes. This retrospective cohort study reveals that elderly individuals with a history of atopy, particularly atopic dermatitis, have improved overall survival and a decreased risk of brain metastasis compared to those without atopy. The study suggests that atopy may enhance immune responses, offering a potential protective effect against melanoma progression and metastasis.
Study shows atopy improves overall survival and reduces brain metastasis risk in cutaneous melanoma patients.
Atopic individuals with melanoma have lower incidence of brain metastasis, suggesting enhanced immune response.
Analysis of elderly melanoma patients reveals atopy, especially dermatitis, improves survival and reduces metastasis.
Atopic dermatitis significantly reduces death hazard and brain metastasis risk in melanoma patients.
Study highlights gender and racial disparities in melanoma brain metastasis and survival rates.
Exploring how eosinophils and immune responses in atopic conditions improve melanoma treatment outcomes.
Insurance covers clinical consultations.
Subscription fee (from $59/month not billed to insurance) covers immunotherapy, shipping & related costs.